OK Biotech Co Ltd
TWSE:4155
OK Biotech Co Ltd
TWSE:4155
Price:
13.45
TWD
-1.1%
Market Closed
Market Cap:
NT$1.9B
Relative Value
The Relative Value of one
OK Biotech Co Ltd
stock under the Base Case scenario is
28.08
TWD.
Compared to the current market price of 13.45 TWD,
OK Biotech Co Ltd
is
Undervalued by 52%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
28.08
TWD
Undervaluation 52%
Multiples Across Competitors
Competitors Multiples
OK Biotech Co Ltd Competitors
OK Biotech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
|
OK Biotech Co Ltd
TWSE:4155
|
1.9B TWD | 1.2 | 27.5 | 18.3 | 34 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.4T JPY | 10.3 | 37.5 | 27.2 | 32.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56.1B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.8B CHF | 3.5 | 37.4 | 14.4 | 28 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
95.5B DKK | 3.5 | 24.1 | 12.8 | 15.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.4B USD | 3.1 | 30.1 | 12.9 | 17.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.4 | 32.9 | 11.5 | 18 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.4 | 16.8 | 54.3 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
39.4B CNY | 8.7 | 23.9 | 21.5 | 21.5 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
38.8B CNY | 3.9 | 22.8 | 34 | 34 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
836.8B JPY | 6.4 | 47.3 | 22.3 | 30.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
